Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

North America Hepatitis B Market Size

The global hepatitis B market was valued at USD 4.63 billion in 2023, with North America holding a significant market share. The market is driven by the rising development of innovative therapies. It is expected to grow at a CAGR of 3.37% during the forecast period of 2024-2032, with the values likely to attain USD 6.45 billion by 2032.

 

North America Hepatitis B Market Outlook

  • Advancements in diagnostic technologies and improvements in healthcare infrastructure are some of the factors that contribute to the market growth.
  • The presence of a supportive regulatory environment that expedites the introduction of novel treatment options is poised to elevate the North America hepatitis B market value and improve clinical outcomes.
  • Increased awareness initiatives and education campaigns regarding hepatitis B are promoting early diagnosis and encouraging more people to seek medical care. This is likely to boost the market demand in the forecast period.

 

North America Hepatitis B Market Report Snapshots

North America Hepatitis B Market Size

North America Hepatitis B Market Analysis

North America Hepatitis B Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The North America hepatitis B market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 3.37% during the forecast period of 2024-2032 and is likely to reach a market value of USD 6.45 billion by 2032. 

Advancements in diagnostic technologies and improvements in healthcare infrastructure are fuelling the demand for the market.

One of the significant trends in the market is the rising development of innovative hepatitis B therapies. In February 2024, GSK plc announced that its investigational antisense oligonucleotide (ASO) bepirovirsen has received Fast Track Designation from the US Food and Drug Administration to treat chronic hepatitis B.

Based on the type, the market is segmented into acute and chronic.

Treatments available in the market include immune modulator drugs, antiviral drugs, hepatoprotectives, vaccines, and surgery. 

By route of administration, the market is divided into oral and parenteral, among others.

Major distribution channels of the market include hospital pharmacies, retail pharmacies, and online pharmacies.

The market segmentation by countries includes the United States of America and Canada.  

The key players in the market are Gilead Sciences, Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), Novartis AG, Pfizer Inc., Sanofi, Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb, and Dynavax Technologies.

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,399

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 5,299

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 6,299

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear=calculateFutureValue(($getReportDetail['base_value']> 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>